Literature DB >> 16132314

Cardiac function assessment in patients with family history of nonhypertrophic cardiomyopathy: a prenatal and postnatal study.

S R F F Pedra1, L K Hornberger, S M Leal, G P Taylor, J F Smallhorn.   

Abstract

Nonobstructive cardiomyopathies (CMs) may be familial in 20â<euro>"55% of cases. Little is known about the role of fetal echocardiography in such cases. We evaluated the cardiac function serially pre- and postnatally in cases with a family history of nonobstructive CM. The fetal and postnatal studies were performed in the echocardiogarphy laboratory at a tertiary institution. Twenty-six cases from 16 families with a family history of CM were studied. Three fetal echocardiograms were performed at or near 18, 25, and 32 weeks of gestation for complete cardiac functional assessment. Postnatally clinical evaluation, electrocardiogram, and an echocardiogram were performed within the first 3 months, with serial reevaluation for those identified with CM. The mean follow-up was 46 +/- 9 months. Abnormal cardiac function was observed in 8 cases (30%). Six had a previously affected sibling, 1 had other family members affected, and 1 had both antecedents. Four had dilated CM diagnosed prenatally of which 1 recovered, 2 died in utero, and 1 died soon after birth. The remaining 4 had normal fetal echoes and were diagnosed with CM in the first 3 months of life. Three had dilated CM with recovery, and 1 had restrictive CM requiring cardiac transplantation. This study demonstrates a high familial recurrence rate of CM. Fetal echo is useful for early diagnosis, although a normal study does not preclude ventricular dysfunction at a later stage, justifying serial prenatal and postnatal evaluation. Early identification may expedite listing for transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 16132314     DOI: 10.1007/s00246-004-0688-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  28 in total

1.  Congenital fibro-elastosis of the endocardium.

Authors:  N F C GOWING
Journal:  J Pathol Bacteriol       Date:  1953-01

2.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

Review 3.  Clinical approach to genetic cardiomyopathy in children.

Authors:  M L Schwartz; G F Cox; A E Lin; M S Korson; A Perez-Atayde; R V Lacro; S E Lipshultz
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

4.  Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility.

Authors:  S D Colan; K M Borow; A Neumann
Journal:  J Am Coll Cardiol       Date:  1984-10       Impact factor: 24.094

5.  Frequency and phenotypes of familial dilated cardiomyopathy.

Authors:  E Grünig; J A Tasman; H Kücherer; W Franz; W Kübler; H A Katus
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

6.  Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history.

Authors:  C P Taliercio; J B Seward; D J Driscoll; L D Fisher; B J Gersh; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-11       Impact factor: 24.094

7.  Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome.

Authors:  Simone R F F Pedra; Jeffrey F Smallhorn; Greg Ryan; David Chitayat; Glenn P Taylor; Rubina Khan; Mohamed Abdolell; Lisa K Hornberger
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

8.  Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation.

Authors:  A Matitiau; A Perez-Atayde; S P Sanders; T Sluysmans; I A Parness; P J Spevak; S D Colan
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

9.  Dilated cardiomyopathy in infants and children.

Authors:  M L Griffin; A Hernandez; T C Martin; D Goldring; R M Bolman; T L Spray; A W Strauss
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

10.  Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study.

Authors:  L K Hornberger; S P Sanders; A J Rein; P J Spevak; I A Parness; S D Colan
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

View more
  4 in total

Review 1.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

2.  Features and outcomes in utero and after birth of fetuses with myocardial disease.

Authors:  Vlasta Fesslova; Maurizio Mongiovì; Salvatore Pipitone; Jelena Brankovic; Laura Villa
Journal:  Int J Pediatr       Date:  2010-10-03

3.  Fetal Echocardiography is Useful for Screening Fetuses with a Family History of Cardiomyopathy.

Authors:  Nicholas B Zaban; Robert K Darragh; John J Parent
Journal:  Pediatr Cardiol       Date:  2020-08-25       Impact factor: 1.655

4.  Stop-gain mutations in PKP2 are associated with a later age of onset of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Paola Berne; Pablo García-Pavía; Ada Doltra; Elena Arbelo; Georgia Sarquella-Brugada; Anna Iglesias; Luis Alonso-Pulpon; Josep Brugada; Ramon Brugada
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.